Mechanisms regulating the development of oligodendrocytes and central nervous system myelin von Mitew, S, Hay, C.M, Peckham, H, Xiao, J, Koenning, M, Emery, B

Volltext

The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia von von Mackensen, S., Harrington, C., Tuddenham, E., Littley, A., Will, A., Fareh, M., Hay, C. R. M., Khair, K.

Volltext

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency von Pike, G. N., Cumming, A. M., Thachil, J., Hay, C. R. M., Burthem, J., Bolton‐Maggs, P. H. B.

Volltext

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference von BERNTORP, E., SHAPIRO, A., ASTERMARK, J., BLANCHETTE, V. S., COLLINS, P. W., DIMICHELE, D., ESCURIOLA, C., HAY, C. R. M., HOOTS, W. K., LEISSINGER, C. A., NEGRIER, C., OLDENBURG, J., PEERLINCK, K., REDING, M. T., HART, C.

Volltext

Dose-Related Safety and Immunogenicity of a Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults von Treanor, John J., Schiff, Gilbert M., Couch, Robert B., Cate, Thomas R., Brady, Rebecca C., Hay, C. Mhorag, Wolff, Mark, She, Dewei, Cox, Manon M. J.

Volltext

The diagnosis and management of factor VIII and IX inhibitors : A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO) von HAY, C. R. M, BAGLIN, T. P, COLLINS, P. W, HILL, F. G. H, KEELING, D. M

Volltext

Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction von Ragni, M. V., DiMichele, D. M., Hay, C. M., Malec, L. M., Seaman, C. D., Li, J., Yabes, J. G., Butenas, S., Brummel-Ziedins, K.

Volltext

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation von Hay, C. R. M., Xiang, H., Scott, M., Collins, P. W., Liesner, R., Dolan, G., Hollingsworth, R.

Volltext

Prognostic value of coronary multidetector CT angiography in patients with an intermediate probability of significant coronary heart disease von HAY, C. S. M, MORSE, R. J, MORGAN-HUGHES, G. J, GOSLING, O, SHAW, S. R, ROOBOTTOM, C. A

Volltext

EUHASS: The European Haemophilia Safety Surveillance system von Makris, M, Calizzani, G, Fischer, K, Gilman, E.A, Hay, C.R.M, Lassila, R, Lambert, T, Ludlam, C.A, Mannucci, P.M

Volltext

Purchasing factor concentrates in the 21st century through competitive tendering von Hay, C. R. M.

Volltext

The immunogenicity of ReFacto AF (moroctocog alfa AF‐CC) in previously untreated patients with haemophilia A in the United Kingdom von Mathias, M. C., Collins, P. W., Palmer, B. P., Chalmers, E., Alamelu, J., Richards, M., Will, A., Hay, C. R. M.

Volltext

Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophilia von Hay, C. R. M., Sharpe, T., Dolan, G.

Volltext

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients von Collins, P. W., Quon, D. V. K., Makris, M., Chowdary, P., Kempton, C. L., Apte, S. J., Ramanan, M. V., Hay, C. R. M., Drobic, B., Hua, Y., Babinchak, T. J., Gomperts, E. D.

Volltext

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures von Zozulya, N., Kessler, C. M., Klukowska, A., Depka, M., Hampton, K., Hay, C. R. M., Jansen, M., Bichler, J., Knaub, S., Rangarajan, S.

Volltext

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy von Choi-Lundberg, Derek L., Lin, Qing, Chang, Yung-Nien, Chiang, Yawen L., Hay, Carl M., Mohajeri, Hasan, Davidson, Beverly L., Bohn, Martha C.

Volltext

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study von Rodriguez, V., Mancuso, M. E., Warad, D., Hay, C. R. M., DiMichele, D. M., Valentino, L., Kenet, G., Kulkarni, R.

Volltext

Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland von Scott, M., Nummi, V., Lassila, R., Xiang, H., Hay, C. R. M.

Volltext

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison von Hay, C. R. M., Palmer, B. P., Chalmers, E. A., Hart, D. P., Liesner, R., Rangarajan, S., Talks, K., Williams, M., Collins, P. W.

Volltext

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99 von Darby, S. C., Keeling, D. M., Spooner, R. J. D., Wan Kan, S., Giangrande, P. L. F., Collins, P. W., Hill, F. G. H., Hay, C. R. M.

Volltext